Company record
WhiteLab Genomics
Updated October 19, 2026 · Presspool
WhiteLab Genomics is a TechBio company using artificial intelligence to design genomic medicines, via its ALFRED AI platform. whitelabgx.com
Funding
Latest announced financing: $26 million, Series B, led by AVP, announced October 6, 2026.
- $26 million Series B, announced October 6, 2026. Led by AVP. New investors Yaday Health and Blast Club joined existing Omnes and Debiopharm; EU-Startups reports the round as €23.2 million. Listed in the AI startup funding roster for October 5–10, 2026. Sources: WhiteLab Genomics press release, EU-Startups.
Of the 31 Series B rounds with exactly stated amounts in dollars on Presspool's weekly rosters since September 21, 2026, WhiteLab Genomics' $26 million is the 30th largest; their median is $52.5 million.
Whether AI names WhiteLab Genomics
- Machine Relations Index: Not cited in any Machine Relations Index answer, May 10, 2026 to October 18, 2026.
Related records
Closest rounds in the roster for October 5–10, 2026: KONST ($30 million Series B, October 9, 2026), Vesta ($30 million Series B, October 8, 2026), Hadrian ($40 million Series B, October 6, 2026), Namespace ($42 million Series B, October 5, 2026), Stuut ($52.5 million Series B, October 7, 2026), Mecka ($60 million Series B, October 7, 2026).
AVP, which led this round, also led Qdrant ($50M Series B, March 12, 2026) and Deepgram ($130M Series C, January 13, 2026).